should allow recognition of any significant increaseor decreasein susceptibility that might occur during the microgravity incubation period as compared to the simultaneously inoculated and incubated ground-based control card MICs. In order to increase the statistical confidence of the MIC results determined in the test system by the astronauts and the ground-based laboratory staff, eachorganism will be tested in triplicate in a blinded fashion.
The goal of this proposed SpaceShuttle experiment using the susceptibility procedures described herein is to confirm or refute those earlier reports of increased resistanceby examining strains representing a wider spectrum of clinically significant speciesand to examine antibiotics of every clinically relevant classand mechanism of action. The susceptibility testing methodology described in this report (special Vitek cards and color growth indicator system)has been developed to facilitate simple, fast, and safe handling and reading by the SpaceShuttle crew with minimal crew time required for the experiment. The authors are hopeful that the final version of this experiment will be scheduled for a SpaceShuttle mission in the near future. The results of that experiment should clarify whether there is any adverse effect of microgravity on the activities of antimicrobial agentsof various classesagainst commonly encountered bacterial pathogens. 
